Morphine, which is a μ-opioid receptor (MOR) agonist, promotes angiogenesis-dependent growth in estrogen-dependent human MCF-7 cell tumor xenografts in mice at physiologically relevant conditions [5]. Here, OPRM1 is linked to neoplasm.